watch

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Buy Glenmark Pharma; target Rs 650: Rahul Mohindar

Glenmark Pharmaceuticals Ltd. video

Buy Glenmark Pharma; target Rs 650: Rahul Mohindar

Executives

Mr. Glenn Saldanha, Chairman & Managing Director
Glenn Saldanha is the Chairman & Managing Director of Glenmark Pharmaceuticals Limited. Glenn joined Glenmark Pharmaceuticals in 1998 as Director and took over as Managing Director & CEO in 2001.

As Chairman & Managing Director of Glenmark Pharmaceuticals Limited, Glenn Saldanha oversees the entire operations of the organization. During his tenure, he has managed to transform Glenmark from an Indian-driven branded generics business into a research-driven innovation-led organization that focuses on discovering new molecules. Simultaneously he has built a strong branded formulations business across emerging economies including India and has also established a strong foothold in the US generics market in a short period.

Mr. Saldanha holds a Bachelor’s Degree in Pharmacy from Mumbai University and is an MBA from Leonard Stern School of Business, New York University. Prior to Glenmark, Mr. Saldanha has worked with Eli Lily, USA and PriceWater House Coopers, USA
Ms. Cheryl Pinto, Director - Corporate Affairs
Cheryl Pinto is Director - Corporate Affairs with Glenmark Pharmaceuticals Limited from October 1999. She is an executive member of the Board of Directors and belongs to the promoter family of the company. Having over 20 years of experience in the pharmaceutical field, she presently heads the company’s Human Resource, Corporate Communications and Corporate Social Responsibility functions. As an entrepreneur Cheryl was the founder of a pharmaceutical company which she served as Managing Director from 1989 to 1999 before joining Glenmark.

Cheryl is a Graduate in Pharmacy from the University Department of Chemical Technology in Mumbai. She has also completed The General Management Programme from the Harvard Business School in Boston.
Mr Rajesh V. Desai, Executive Director
Mr Rajesh V. Desai is the Chief Financial Officer of Glenmark Pharmaceuticals Ltd. and has been in the organization for close to three decades. A Science graduate from Bombay University and a Chartered Accountant from Institute of Chartered Accountants of India, Rajesh is responsible for the Finance, Legal and IT function of the entire organization. A member of the leadership team for over a decade, Rajesh has been responsible for charting the Company's growth in the domestic and overseas markets.

News & Analysis

You may also be interested in: